The eight-member ARUP Consult Editorial Board made up of University of Utah Department of Pathology faculty and residents helps lead innovative and ongoing improvements to ARUP Consult. Members work with the ARUP Consult editorial team to establish development goals and set priorities, and to periodically review and update the Consult Editorial Policy.
Members of the ARUP Consult Editorial Board include (from the left): Lisa M. Johnson, PhD; Jordon March, MD; Tracy I. George, MD; Brian R. Jackson, MD, MS; Kamisha L. Johnson-Davis, PhD; Yuan Ji, PhD; and Patricia R. Slev, PhD. Zachary Dong, MD, is not pictured.
Dr. George completed her MD and residency training in anatomic pathology and laboratory medicine at the University of California, San Francisco, with fellowships in hematopathology and surgical pathology at Stanford University.
She is board certified in anatomic pathology, clinical pathology, and hematology by the American Board of Pathology. Her research interests include mast cell disease and laboratory hematology.
Dr. George has authored more than 100 publications, is president elect of scientific communications for the International Society for Laboratory Hematology, and coeditor in chief of the International Journal of Laboratory Hematology. She received the College of American Pathologists Lifetime Achievement Award in 2014.
Dr. Jackson directs the Informatics Department at ARUP, including ARUP Consult, decision support, test utilization management, and software product management. He received his BA in mathematics, his MS in medical informatics, and his MD from the University of Utah, and completed a clinical pathology residency at Dartmouth-Hitchcock Medical Center. Before joining ARUP, Dr. Jackson was a staff clinical pathologist and informaticist at Dartmouth-Hitchcock Medical Center, a product manager for a Belgium-based medical software firm, and a National Library of Medicine informatics fellow at the U of U.
Dr. Jackson’s research interests include economic analysis of diagnostic testing, physician utilization of laboratory tests, and corporate social responsibility in healthcare. He is certified in clinical pathology by the American Board of Pathology.
Dr. Ji received her PhD in molecular pharmacology and experimental therapeutics at the Mayo Clinic in Rochester, Minn., where she also completed a postdoctoral research fellowship in pharmacogenomics and pharmacometabolomics, a National Institutes of Health (NIH) T32 Clinical Pharmacology Fellowship, and an American Board of Medical Genetics and Genomics fellowship in clinical molecular genetics.
Dr. Ji received multiple early-career development awards and grants, including an NIH-KL2 Mentored Career Award and a Minnesota Partnership for Biotechnology and Medical Genomics Award.
Dr. Ji is board certified in clinical pharmacology and medical genetics and genomics, and she currently serves as program director for the Laboratory Genetics and Genomics Fellowship at the U of U School of Medicine. Dr. Ji’s major clinical and research focus is in pharmacogenomics, and she has coauthored several instrumental clinical guidelines for clinical pharmacogenomics testing and implementation. Dr. Ji has also endeavored to develop a valued-added model for noninvasive prenatal testing from a reference laboratory perspective as the test director.
Dr. Johnson received her BA in chemistry from the University of Minnesota, Morris, and her PhD in chemistry from the University of Wisconsin, Madison.
She was a postdoctoral research associate at University of California, Los Angeles, and completed a postdoctoral fellowship in clinical chemistry at the University of Minnesota Department of Laboratory Medicine and Pathology.
Dr. Johnson is a diplomate of the American Board of Clinical Chemistry and a member of the American Association for Clinical Chemistry.
Dr. Johnson-Davis received her BS in biochemistry from the University of California, Riverside, and her PhD in pharmacology from the University of Utah. She was a postdoctoral research associate at the Center for Human Toxicology and completed a postdoctoral fellowship in clinical chemistry at the U of U School of Medicine Department of Pathology.
Dr. Johnson-Davis is board certified in clinical chemistry and toxicological chemistry. She is a diplomate of the American Board of Clinical Chemistry and a fellow of the National Association of Clinical Biochemistry and the Association of Clinical Scientists.
Dr. Slev earned her PhD in immunology and laboratory medicine from the University of Florida, Gainesville, and completed a fellowship in clinical chemistry at the University of Utah.
Her research interests are in immunogenetics and pathogen interactions, particularly HIV and viral hepatitis.
Dr. Dong completed his undergraduate degree at Regis University before graduating from the University of Pittsburgh School of Medicine.
He has lived in five states and two countries, and is a native of the Pacific Northwest and Mountain West.
Dr. March received his BS in microbiology and bacteriology from Brigham Young University, where he developed polymerase chain reaction-based and gas chromatography-mass spectrometry-based assays for the rapid identification and differentiation of numerous CDC select agents.
He received his MD degree from the University of Nevada, Reno, School of Medicine. While in medical school, he studied various modalities for the detection and diagnosis of melanoma.
Dr. March’s academic interests include medical education optimization and digital pathology utilization.